Authors: Nyronen, T Pihlavisto, M Peltonen, JM Hoffren, AM Varis, M Salminen, T Wurster, S Marjamaki, A Kanerva, L Katainen, E Laaksonen, L Savola, JM Scheinin, M Johnson, MS

Citation: T. Nyronen et al., Molecular mechanism for agonist-promoted alpha(2A)-adrenoceptor activationby norepinephrine and epinephrine, MOLEC PHARM, 59(5), 2001, pp. 1343-1354

Authors: Mustonen, P Savola, JM Lassila, R

Citation: P. Mustonen et al., Atipamezole, an imidazoline-type alpha(2)-adrenoceptor inhibitor, binds tohuman platelets and inhibits their adrenaline-induced aggregation more effectively than yohimbine, THROMB RES, 99(3), 2000, pp. 231-237

Authors: Salminen, T Varis, M Nyronen, T Pihlavisto, M Hoffren, AM Lonnberg, T Marjamaki, A Frang, H Savola, JM Scheinin, M Johnson, MS

Citation: T. Salminen et al., Three-dimensional models of alpha(2A)-adrenergic receptor complexes provide a structural explanation for ligand binding, J BIOL CHEM, 274(33), 1999, pp. 23405-23413

Authors: Jansson, CC Pohjanoksa, K Lang, J Wurster, S Savola, JM Scheinin, M

Citation: Cc. Jansson et al., alpha(2)-adrenoceptor agonists stimulate high-affinity GTPase activity in a receptor subtype-selective manner, EUR J PHARM, 374(1), 1999, pp. 137-146